08/16/2024 4:50 PM | Harris Todd (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/16/2024 4:55 PM | Bensen Daniel (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/16/2024 4:18 PM | Fuhrman Alan (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 6:10 PM | Bensen Daniel (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 2:08 PM | Bensen Daniel (Reporting) Tyra Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2024 5:26 PM | Kolchinsky Peter (Reporting) RA Capital Healthcare Fund LP (Reporting) RA CAPITAL MANAGEMENT, L.P. (Reporting) RA Capital Nexus Fund, L.P. (Reporting) Shah Rajeev M. (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2024 3:30 PM | Kjellson Nina S (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
05/31/2024 3:30 PM | MORE ROBERT J (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2024 3:30 PM | KAPLAN GILLA (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2024 3:30 PM | Subramony Siddarth (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2024 3:30 PM | Tyra Biosciences (Issuer) Verjee Rehan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2024 3:30 PM | Simson Jake (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/09/2024 3:46 PM | Rothenberg Stephen Michael (Reporting) Tyra Biosciences (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
05/09/2024 3:48 PM | Rothenberg Stephen Michael (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/09/2024 3:49 PM | Moran Susan (Reporting) Tyra Biosciences (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
05/09/2024 3:49 PM | Moran Susan (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/09/2024 3:08 PM | Tyra Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/22/2024 11:15 PM | Tyra Biosciences (Filer)
| Form EFFECT | |
04/05/2024 3:20 PM | Tyra Biosciences (Filer)
| Form PRE 14A | |
03/19/2024 6:58 PM | Tada Hiroomi (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 7:01 PM | Fuhrman Alan (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 6:38 PM | Harris Todd (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 3:33 PM | Tyra Biosciences (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
03/19/2024 3:35 PM | Tyra Biosciences (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/13/2024 4:46 PM | Bensen Daniel (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:19 AM | FMR LLC (Filed by) Tyra Biosciences (Subject)
| Form SC 13G/A | |
03/08/2024 4:38 PM | Bensen Daniel (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 4:40 PM | Bensen Daniel (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 5:58 PM | Bensen Daniel (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 8:00 PM | Bensen Daniel (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 8:24 AM | BIOTECHNOLOGY VALUE FUND L P (Filed by) Tyra Biosciences (Subject)
| Form SC 13G/A | |
02/09/2024 6:26 PM | Bensen Daniel (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 9:05 AM | FMR LLC (Filed by) Tyra Biosciences (Subject)
| Form SC 13G/A | |
02/08/2024 4:10 PM | Boxer Capital, LLC (Filed by) Tyra Biosciences (Subject)
| Form SC 13D/A | |
02/08/2024 4:16 PM | Kolchinsky Peter (Reporting) RA Capital Healthcare Fund LP (Reporting) RA CAPITAL MANAGEMENT, L.P. (Reporting) RA Capital Nexus Fund, L.P. (Reporting) Shah Rajeev M. (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 4:09 PM | Boxer Asset Management Inc. (Reporting) Boxer Capital, LLC (Reporting) Davis Aaron I. (Reporting) LEWIS JOSEPH (Reporting) MVA Investors, LLC (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/06/2024 7:22 PM | Harris Todd (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/06/2024 7:23 PM | Bensen Daniel (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/06/2024 3:56 PM | Bensen Daniel (Reporting) Tyra Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/06/2024 3:40 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by) Tyra Biosciences (Subject)
| Form SC 13D/A | |
02/05/2024 5:05 AM | Tyra Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
“Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad) Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide.
It will give them unprecedented powers to control your bank account.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9288&Placement=NativeDisplay&Source=NativeDisplay) Learn these 4 simple steps and protect your savings before it’s too late. |
02/02/2024 4:04 PM | Bensen Daniel (Reporting) Tyra Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024 3:47 PM | Harris Todd (Reporting) Tyra Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024 4:24 PM | Tyra Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/22/2023 8:00 AM | Tyra Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/07/2023 3:16 PM | Tyra Biosciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/26/2023 3:50 PM | Tyra Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/19/2023 6:27 PM | Fuhrman Alan (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2023 6:36 PM | Harris Todd (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2023 6:37 PM | Tada Hiroomi (Reporting) Tyra Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |